The US and Canada have healthcare, life science and medical device industries that are complex and interconnected.

On March 6, President Donald Trump instituted a 25 percent ad valorem rate of duty on goods imported from Canada under the International Emergency Economic Powers Act.[1] The tariffs will not be implemented on goods that comply with the United States-MexicoCanada Agreement until April 2.[2] In turn, Canada has announced a $155 billion tariff package on the US.[3]

Download the full Law360 article, "Mitigating Tariff Risks For Healthcare In US And Canada."



Contacts

Jeff Wurzburg
Jeff Wurzburg
Partner
Email
jeff.wurzburg@nortonrosefulbright.com
T: +1 210 270 9338
Vanessa Grant
Vanessa Grant
Senior Partner
Email
vanessa.grant@nortonrosefulbright.com
T: +1 416 216 4056

Practice areas:

Industry:

Recent publications

Lines of code

Event

2025 Insurathon: Pitch to win £50,000 of investment and pro bono UK legal advice

The Insurathon is a Norton Rose Fulbright event which fosters technological advancements and innovation in the insurance sector, now in its eighth year.

Global | January 13, 2025

InsurTech
IAR-Issue-22_Assests_Website-hero

Publication

International arbitration report

In this edition, we focused on the Shanghai International Economic and Trade Arbitration Commission’s (SHIAC) new arbitration rules, which take effect January 1, 2024.

Global | November 19, 2024

International arbitration
creative-communication-and-internet-network-connect-in-smart-city

Publication

Regulation Around the World: Financial service regulation, investment research

In this edition of Regulation Around the World we review recent steps that financial services regulatory authorities have taken as regards investment research.

Global | April 26, 2024

Financial services and regulation
Site search

Subscribe and stay up to date with the latest legal news, information and events . . .

Register now